|
|
|
Insider
Information: |
Karnani Vikram |
Relationship: |
EVP & President, Inter... |
City: |
Dublin |
State: |
L2 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
104,165 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,947,870 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
104,165 |
|
|
Total
Value |
$2,947,870 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
EVP & President, Inter... |
2021-02-22 |
104,165 |
2017-03-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-01-06 |
4 |
AS |
$35.62 |
$331,159 |
D/D |
(9,297) |
78,146 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-01-21 |
4/A |
D |
$38.25 |
$83,117 |
D/D |
(2,173) |
80,877 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
4,904 |
83,050 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,007 |
95,884 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-02-19 |
4 |
D |
$36.06 |
$239,763 |
D/D |
(6,649) |
89,235 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-04-28 |
4 |
AS |
$35.01 |
$1,052,506 |
D/D |
(30,063) |
59,172 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-04-29 |
4 |
AS |
$35.00 |
$548,905 |
D/D |
(15,683) |
43,489 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
EVP, Chief Commercial Officer |
|
2020-06-01 |
4 |
AS |
$50.23 |
$118,995 |
D/D |
(2,369) |
42,169 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
|
2017-03-23 |
4 |
D |
$14.56 |
$43,025 |
D/D |
(2,955) |
27,059 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
|
2017-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,500 |
30,014 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
|
2017-07-31 |
4 |
D |
$11.98 |
$31,891 |
D/D |
(2,662) |
31,500 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
SVP, Rheumatology Bus. Unit |
|
2017-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,675 |
34,162 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|